GWSA
AZN icon

Global Wealth Strategies & Associates’s AstraZeneca AZN Stock Holding History

Global Wealth Strategies & Associates’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-125
Closed -$23K – 546
2025
Q4 		$23K Buy
+125
New +$21.9K 0.01% 230
2025
Q1 		– Sell
-63
Closed -$8.26K – 477
2024
Q4 		$8.26K Hold
63
– – ﹤0.01% 237
2024
Q3 		$9.82K Hold
63
– – ﹤0.01% 198
2024
Q2 		$9.83K Hold
63
– – ﹤0.01% 177
2024
Q1 		$8.54K Hold
63
– – ﹤0.01% 192
2023
Q4 		$8.49K Hold
63
– – ﹤0.01% 178
2023
Q3 		$8.53K Hold
63
– – ﹤0.01% 172
2023
Q2 		$9.02K Hold
63
– – ﹤0.01% 169
2023
Q1 		$8.75K Sell
63
-3
-5% -$404 ﹤0.01% 177
2022
Q4 		$8.88K Buy
+66
New +$8.28K 0.01% 159

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Global Wealth Strategies & Associates's AZN Position: Q1 2026 in Review

Global Wealth Strategies & Associates sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 125 shares — an estimated $23K sold.

Global Wealth Strategies & Associates first reported a position in AZN in Q4 2022 and held it in 10 quarters. The position peaked at $23K in Q4 2025. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Global Wealth Strategies & Associates reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Global Wealth Strategies & Associates sold 125 AstraZeneca shares in Q1 2026, an estimated $23K.
  • Global Wealth Strategies & Associates first reported a position in AstraZeneca in Q4 2022 and held it in 10 quarters.
  • Global Wealth Strategies & Associates's AstraZeneca position peaked at $23K in Q4 2025.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Global Wealth Strategies & Associates's 13F filing for Q1 2026, filed 3 Apr 2026.